Antimicrobial peptides (AMPs) have been shown to exhibit cytotoxic effects against various cancer cell lines (Tornesello et al., 2020), including breast cancer, lung cancer, melanoma, leukemia, and lymphoma. The gene discussed is ADSL; the disease is breast cancer.